Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141079 |
| CAS No | 88205-32-7 |
| Mol.F. | C20H24N2O5 |
| Mol.Wt. | 372.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141080 |
| CAS No | NA |
| Mol.F. | C11H13Cl2N3O3 |
| Mol.Wt. | 306.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141081 |
| CAS No | NA |
| Mol.F. | C11H11Cl2N3O5 |
| Mol.Wt. | 336.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141082 |
| CAS No | NA |
| Mol.F. | C26H36N6O3 |
| Mol.Wt. | 480.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141083 |
| CAS No | NA |
| Mol.F. | C23H32N6O3 |
| Mol.Wt. | 440.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141084 |
| CAS No | NA |
| Mol.F. | C25H34N6O3 |
| Mol.Wt. | 466.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141085 |
| CAS No | NA |
| Mol.F. | C18H24N4O3 |
| Mol.Wt. | 344.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141086 |
| CAS No | NA |
| Mol.F. | C6H9N3O2 |
| Mol.Wt. | 155.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141087 |
| CAS No | NA |
| Mol.F. | C20H25N3O2 |
| Mol.Wt. | 339.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141088 |
| CAS No | NA |
| Mol.F. | C20H26N2O4 |
| Mol.Wt. | 358.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141089 |
| CAS No | NA |
| Mol.F. | C22H24N4O3 |
| Mol.Wt. | 392.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141090 |
| CAS No | NA |
| Mol.F. | C22H24N4O3 |
| Mol.Wt. | 392.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141091 |
| CAS No | NA |
| Mol.F. | C22H23N5O4 |
| Mol.Wt. | 421.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141092 |
| CAS No | NA |
| Mol.F. | C16H20N6O2 |
| Mol.Wt. | 328.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141093 |
| CAS No | NA |
| Mol.F. | C13H19N3O |
| Mol.Wt. | 233.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141094 |
| CAS No | 1233340-43-6 |
| Mol.F. | C4H4N2O |
| Mol.Wt. | 96.1 |
| INV STATUS | CUSTOM SYNTHESIS |